Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8.56M
-
Number of holders
-
128
-
Total 13F shares, excl. options
-
87.7M
-
Shares change
-
+671K
-
Total reported value, excl. options
-
$683M
-
Value change
-
+$4.02M
-
Number of buys
-
61
-
Number of sells
-
-62
-
Price
-
$7.79
Significant Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q2 2022
155 filings reported holding ATRA - Atara Biotherapeutics, Inc. - Common Stock as of Q2 2022.
Atara Biotherapeutics, Inc. - Common Stock (ATRA) has 128 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 87.7M shares
.
Largest 10 shareholders include JPMORGAN CHASE & CO (8.86M shares), BAUPOST GROUP LLC/MA (8.12M shares), MAVERICK CAPITAL LTD (7.86M shares), VANGUARD GROUP INC (7.3M shares), Redmile Group, LLC (6.24M shares), STATE STREET CORP (6.22M shares), FMR LLC (5.85M shares), WASATCH ADVISORS INC (5.13M shares), Point72 Asset Management, L.P. (3.88M shares), and GOLDMAN SACHS GROUP INC (2.94M shares).
This table shows the top 128 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.